BCHE and Alzheimer disease: Nevertheless, both PDD and AD are associated with marked cholinergic deficits (to a greater extent in PDD than in AD) (23,24) and it is these deficits that underlie the rationale for cholinesterase inhibitor therapy in both conditions.